Evidence map›Paper›PMID 36344511›Full record

ArticleNature communications2022

Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51.

Anne Margriet Heijink, Colin Stok, David Porubsky, Eleni Maria Manolika, Jurrian K de Kanter, Yannick P Kok, Marieke Everts, H Rudolf de Boer, Anastasia Audrey, Femke J Bakker and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. POLQ to the rescue for double-strand break repair during mitosis.Nature structural & molecular biology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Polymerase θ inhibition steps on the cGAS pedal.The Journal of clinical investigation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 4 countries.

Anne Margriet Heijink *Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.
Colin Stok *Department of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.
David PorubskyEuropean Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands.
Eleni Maria ManolikaDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000, CA, Rotterdam, the Netherlands.
Jurrian K de KanterPrincess Máxima Center for Pediatric Oncology, 3584, CS, Utrecht, the Netherlands.
Yannick P KokDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.
Marieke EvertsDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.
H Rudolf de BoerDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.ORCID 0000-0002-8386-8184
Anastasia AudreyDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.
Femke J BakkerDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.ORCID 0000-0002-6078-8333
Elles WierengaDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands.
Marcel TijstermanDepartment of Human Genetics, Leiden University Medical Center, 2333 ZC, Leiden, the Netherlands.ORCID 0000-0001-8465-9002
Victor GuryevEuropean Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands.ORCID 0000-0002-5810-6022
Diana C J SpieringsEuropean Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands.ORCID 0000-0001-8403-474X
Puck KnipscheerOncode Institute, 3521 AL, Utrecht, the Netherlands.ORCID 0000-0003-4198-0132
Ruben van BoxtelPrincess Máxima Center for Pediatric Oncology, 3584, CS, Utrecht, the Netherlands.ORCID 0000-0003-1285-2836
Arnab Ray ChaudhuriDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000, CA, Rotterdam, the Netherlands.
Peter M LansdorpEuropean Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713GZ, Groningen, the Netherlands. plansdor@bccrc.ca.ORCID 0000-0001-7435-1071
Marcel A T M van VugtDepartment of Medical Oncology, University Medical Center Groningen, University of Groningen, the Netherlands, 9713GZ, Groningen, the Netherlands. m.vugt@umcg.nl.ORCID 0000-0002-3202-4678
University Medical Center Groningen · NLErasmus MC · NLOncode Institute · NLBC Cancer Agency · CALeiden University Medical Center · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sister chromatid exchanges (SCEs) are products of joint DNA molecule resolution, and are considered to form through homologous recombination (HR). Indeed, SCE induction upon irradiation requires the canonical HR factors BRCA1, BRCA2 and RAD51. In contrast, replication-blocking agents, including PARP inhibitors, induce SCEs independently of BRCA1, BRCA2 and RAD51. PARP inhibitor-induced SCEs are enriched at difficult-to-replicate genomic regions, including common fragile sites (CFSs). PARP inhibitor-induced replication lesions are transmitted into mitosis, suggesting that SCEs can originate from mitotic processing of under-replicated DNA. Proteomics analysis reveals mitotic recruitment of DNA polymerase theta (POLQ) to synthetic DNA ends. POLQ inactivation results in reduced SCE numbers and severe chromosome fragmentation upon PARP inhibition in HR-deficient cells. Accordingly, analysis of CFSs in cancer genomes reveals frequent allelic deletions, flanked by signatures of POLQ-mediated repair. Combined, we show PARP inhibition generates under-replicated DNA, which is processed into SCEs during mitosis, independently of canonical HR factors.

Indexed as

Poly(ADP-ribose) Polymerase InhibitorsSister Chromatid ExchangeChromosome Fragile SitesDNAHomologous RecombinationDNAPoly(ADP-ribose) Polymerase Inhibitors

Identifiers

PMID36344511
PMCPMC9640580
OpenAlexW4308770211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.